SUBSCRIBE
Drivetime Radio

Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.

Current programs include:

  • NEW Neurology – hosted by Prof Mark Cook, Neurologist, Melbourne
  • NEW Ophthalmology – hosted by Prof Paul Mitchell, Ophthalmologist, Sydney
  • Psychiatry – hosted by Prof Malcolm Hopwood, Psychiatrist, Melbourne
  • Respiratory – hosted by Prof John Upham, Respiratory Physician, Brisbane

More disciplines coming soon……

Podcasts are available for each series – providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions

You can also listen online – either search by your area of interest to filter interviews relevant to you, or if you are logged in you can click on specific programs below.

Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.

Search Interviews

By area of interest:

Specialty Interviews

Oph.1The NEW KeepSight screening initiative needs your help (29 mins)
00:00
Preview
10 seconds
Show more information

NEW Ophthalmology. Led by Diabetes Australia and Vision 2020 Australia, the NEW KeepSight initiative will engage with 1.27 million people with diabetes who are registered on the National Diabetes Services Scheme (NDSS). How will the KeepSight program ultimately change the management of diabetic retinopathy in Australia, and what do you as ophthalmologists need to do?

Hosted by

Professor Paul Mitchell

Interviewees

  • Dr Peter van Wijngaarden, Interim Managing Director, Centre for Eye Research Australia & Consultant Ophthalmologist, The Royal Victorian Eye and Ear HospitalDr Peter van Wijngaarden, Interim Managing Director, Centre for Eye Research Australia & Consultant Ophthalmologist, The Royal Victorian Eye and Ear Hospital
Oph.2Principles of treatment in diagnosed non-proliferative diabetic retinopathy absent of macular oedema (22 mins)
00:00
Preview
10 seconds
Show more information

NEW Ophthalmology. New screening programs in Australia will help improve the detection rates of diabetic retinopathy, leading to earlier detection and treatment. Early detection and treatment can prevent the majority of vision loss and blindness in patients with diabetes, so how can we shift the care from what is now, very expensive hospital-based care, where ophthalmologists need laser treatment and intensive anti-VEFG injections, towards more primary and secondary care?

Hosted by

Professor Paul Mitchell

Interviewees

  • Prof. Tien Y Wong, MD, PhD, Professor & Medical Director, Singapore National Eye Center, Chairman, Singapore Eye Research Institute & Vice-Dean, Duke-NUS Medical School, National University of SingaporeProf. Tien Y Wong, MD, PhD, Professor & Medical Director, Singapore National Eye Center, Chairman, Singapore Eye Research Institute & Vice-Dean, Duke-NUS Medical School, National University of Singapore
Neu.1Insights from an Epileptologist (23 mins)
00:00
Preview
10 seconds
Show more information

NEW Neurology. Making a diagnosis of epilepsy can be difficult, particularly establishing the difference between focal and generalised seizures, and this differential is critical. In this interview we discuss this, as well as how to ensure the patient gets the right treatment, early on.

Hosted by

Professor Mark Cook

Interviewees

  • A/Prof. Wendyl D’Souza, Epileptologist, St Vincent’s Hospital, MelbourneA/Prof. Wendyl D’Souza, Epileptologist, St Vincent’s Hospital, Melbourne
Neu.2Driving & Epilepsy (27 mins)
00:00
Preview
10 seconds
Show more information

NEW Neurology. One of the most difficult areas of practice for neurologists are the rules and regulations around driving with epilepsy. There’s a lot of confusion and immense interest in this topic, so in this interview we discuss the social consequences and the practical issues.

Hosted by

Professor Mark Cook

Interviewees

  • Prof. Ernest Somerville, Neurologist, Sydney, Chair of Australian & New Zealand Association of Neurologists’ Driving CommitteeProf. Ernest Somerville, Neurologist, Sydney, Chair of Australian & New Zealand Association of Neurologists’ Driving Committee
Resp.1How can you reduce the oral corticosteroid burden in patients with severe refractory asthma? (19 mins)
00:00
Preview
10 seconds
Show more information

NEW Respiratory. In terms of difficult asthma, we’re in very exciting times! We now have the opportunity to substantially minimise exposure of patients to oral corticosteroids to try and minimise the burden of illness. In this interview we discuss identifying patients that would benefit from a reduction in oral corticosteroids, tips on down-titrating oral corticosteroids and starting patients on biologic agents.

Hosted by

Professor John Upham

Interviewees

  • Prof. Peter Wark, Senior Staff Specialist, Respiratory & Sleep Medicine, John Hunter Hospital, Newcastle & Conjoint Professor, University of NewcastleProf. Peter Wark, Senior Staff Specialist, Respiratory & Sleep Medicine, John Hunter Hospital, Newcastle & Conjoint Professor, University of Newcastle
Resp.2Severe refractory asthma – which patients are suitable for a biologic agent? (21 mins)
00:00
Preview
10 seconds
Show more information

NEW Respiratory. There are now three biologic agents for severe refractory asthma available in Australia. These agents when chosen appropriately can improve asthma control and decrease the risk of exacerbations. We need to ensure that these therapies are given to the right sort of patient, so what factors do we need to consider?

Hosted by

Professor John Upham

Interviewees

  • Prof Paul Thomas, Respiratory & Sleep Medicine Physician, SydneyProf Paul Thomas, Respiratory & Sleep Medicine Physician, Sydney
Psyc.1Part a) The treatment of schizophrenia – thinking long term from the beginning (23 mins)
00:00
Preview
10 seconds
Show more information

NEW Psychiatry. People with psychotic disorders have high levels of co-morbidity and sadly their life expectancy is reduced by 10-25 years. Thinking long-term from the beginning is key, so in the first part of this interview we discuss the efficacy across all current treatments and the side effect profile, including short-term effects such as sedation and long-term concerns with weight and particularly metabolic functioning.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Dr Christoph Correll, Professor of Psychiatry, the Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, New YorkDr Christoph Correll, Professor of Psychiatry, the Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, New York
Psyc.2Part b) Schizophrenia and the treatment armamentarium (14 mins)
00:00
Preview
10 seconds
Show more information

NEW Psychiatry. We now have more options within the atypical antipsychotic range, so in the second part of this interview with Cristoph Correll, we discuss the evidence for effective medications that also have relatively little cardiometabolic burden.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Dr Christoph Correll, Professor of Psychiatry, the Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, New YorkDr Christoph Correll, Professor of Psychiatry, the Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, New York
Psyc.3What is different about Valdoxan? (8 mins)
00:00
Preview
10 seconds
Show more information

NEW Psychiatry. In this interview we discuss the link between depression and altered circadian rhythm, plus the role of melatonergic receptors and 5HT-2C receptors in the regulation of circadian rhythm and the treatment of depression.

Hosted by

Dr Ginni Mansberg

Interviewees

  • Dr Stephen Stahl, University of California, San DiegoDr Stephen Stahl, University of California, San Diego
Psyc.4The patient-centred approach to treating depression (14 mins)
00:00
Preview
10 seconds
Show more information

NEW Psychiatry. Identifying symptoms of depression and patient willingness to start treatment are key challenges to effective treatment. Patient preference, as well as the features of the episode are important considerations, so we talk to both a patient and David Horgan about patient-centred care for depression.

Hosted by

Dr Ginni Mansberg

Interviewees

  • Associate Professor David Horgan, Psychiatrist, VictoriaAssociate Professor David Horgan, Psychiatrist, Victoria
Page 1 of 212

Search Interviews

By area of interest:

Exclusively for Australian healthcare professionals
×

Tap the share icon ios share icon and select 'Add to Home Screen' to add the site to your home screen for quick access!